Magnetic Nanohybrids for Cancer Therapy

ended

The MaNaCa project intends to develop the scientific and technological capacity as well as raising the research profile of the Institute for Physical Research of the National Academy of Sciences (IPR-NAS) in Armenia. From a scientific standpoint, MaNaCa will focus on the structural and magnetic characterization of magnetic nanohybrids and their application for cancer therapy. The project's aim will be accomplished by networking IPR-NAS with two internationally-leading research organisations: the Aristotle University of Thessaloniki (AUTH) in Greece and the University of Duisburg – Essen (UDE) in Germany. Throughout the project, the research partners will be supported for management ad dissemination by Intelligentsia Consultants Sàrl (INT), a consultancy company based in Luxembourg which has already collaborated on several occasions with the Widening partner. During the project, which will have a total duration of three years, the partners will carry out a research and innovation strategy with these objectives: 1. Stimulating scientific excellence and innovation capacity of IPR-NAS with regard to magnetic nanohybrids for cancer therapy. 2. Improve the career prospects of early stage researchers of IPR-NAS and the Twinning partners 3. Raise the research profile of IPR-NAS and the Twinning Partners In order to accomplish this task, the consortium partners will implement several actions through the project’s work packages: (WP1) exchange of senior researchers; (WP2) exchange of early stage researchers; and (WP3) dissemination and oureach. Project management (WP4) will be coordinated by IPR-NAS with the support of INT. In addition to staff exchanges, project's activities will include technical training, joint publications, joint participation to conferences, organization of summer schools, workshops and an international conference.